Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 30,788 shares at $127.75 ($4.0M) on 2020-05-13, disclosed to the SEC on 2020-05-15.
Open-market sale of $4.0M RGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.77 | 5,358 | $679K | 17.1% |
| 2 | $126.77 | 5,358 | $679K | 17.1% |
| 3 | $127.75 | 2,865 | $366K | 9.2% |
| 4 | $127.75 | 2,865 | $366K | 9.2% |
| 5 | $128.70 | 1,612 | $207K | 5.2% |
| 6 | $128.70 | 1,612 |
| $207K |
| 5.2% |
| 7 | $130.20 | 1,700 | $221K | 5.6% |
| 8 | $130.20 | 1,700 | $221K | 5.6% |
| 9 | $131.38 | 3,013 | $396K | 10.0% |
| 10 | $131.38 | 3,013 | $396K | 10.0% |
| 11 | $132.37 | 846 | $112K | 2.8% |
| 12 | $132.37 | 846 | $112K | 2.8% |
| Total | $128.74 avg | 30,788 | $4.0M | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |